SG Americas Securities LLC lessened its stake in shares of Stryker Corporation (NYSE:SYK) by 95.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,711 shares of the medical technology company’s stock after selling 393,629 shares during the quarter. SG Americas Securities LLC’s holdings in Stryker Corporation were worth $2,597,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the business. Vanguard Group Inc. boosted its stake in Stryker Corporation by 5.2% during the first quarter. Vanguard Group Inc. now owns 23,421,053 shares of the medical technology company’s stock worth $3,083,382,000 after buying an additional 1,161,688 shares during the period. BlackRock Inc. boosted its stake in Stryker Corporation by 2,526.4% during the first quarter. BlackRock Inc. now owns 21,976,771 shares of the medical technology company’s stock worth $2,893,242,000 after buying an additional 21,140,000 shares during the period. Fundsmith LLP boosted its stake in Stryker Corporation by 4.6% during the first quarter. Fundsmith LLP now owns 5,175,453 shares of the medical technology company’s stock worth $681,348,000 after buying an additional 226,057 shares during the period. Wellington Management Group LLP boosted its stake in Stryker Corporation by 0.5% during the first quarter. Wellington Management Group LLP now owns 4,569,118 shares of the medical technology company’s stock worth $601,525,000 after buying an additional 24,139 shares during the period. Finally, Geode Capital Management LLC boosted its stake in Stryker Corporation by 6.3% during the first quarter. Geode Capital Management LLC now owns 2,786,406 shares of the medical technology company’s stock worth $366,255,000 after buying an additional 166,133 shares during the period. 74.18% of the stock is owned by institutional investors.

Shares of Stryker Corporation (SYK) opened at 143.03 on Thursday. The company has a 50-day moving average of $143.90 and a 200 day moving average of $138.47. The firm has a market cap of $53.50 billion, a PE ratio of 31.93 and a beta of 0.81. Stryker Corporation has a one year low of $106.48 and a one year high of $148.84.

Stryker Corporation (NYSE:SYK) last released its quarterly earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.51 by $0.02. The firm had revenue of $3.01 billion during the quarter, compared to analysts’ expectations of $2.98 billion. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. Stryker Corporation’s quarterly revenue was up 6.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.39 EPS. On average, equities research analysts expect that Stryker Corporation will post $6.46 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Shareholders of record on Friday, September 29th will be issued a $0.425 dividend. This represents a $1.70 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date of this dividend is Thursday, September 28th. Stryker Corporation’s dividend payout ratio is presently 37.95%.

Several research analysts have weighed in on SYK shares. Morgan Stanley increased their target price on shares of Stryker Corporation from $145.00 to $155.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 21st. Royal Bank Of Canada reaffirmed a “buy” rating and set a $155.00 target price on shares of Stryker Corporation in a research note on Friday, September 1st. Cantor Fitzgerald started coverage on shares of Stryker Corporation in a research note on Thursday, June 29th. They set a “neutral” rating and a $153.00 target price for the company. BidaskClub lowered shares of Stryker Corporation from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 13th. Finally, Zacks Investment Research raised shares of Stryker Corporation from a “hold” rating to a “buy” rating and set a $163.00 price target on the stock in a research report on Monday, July 17th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and twelve have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $145.73.

COPYRIGHT VIOLATION NOTICE: “Stryker Corporation (SYK) Shares Sold by SG Americas Securities LLC” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The original version of this piece of content can be read at https://www.thecerbatgem.com/2017/09/14/stryker-corporation-syk-shares-sold-by-sg-americas-securities-llc.html.

In other Stryker Corporation news, insider Lonny J. Carpenter sold 5,000 shares of the company’s stock in a transaction that occurred on Friday, August 4th. The stock was sold at an average price of $146.36, for a total value of $731,800.00. Following the completion of the transaction, the insider now owns 88,207 shares in the company, valued at approximately $12,909,976.52. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Graham A. Mclean sold 1,124 shares of the company’s stock in a transaction that occurred on Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total value of $164,396.24. Following the completion of the transaction, the insider now owns 8,983 shares of the company’s stock, valued at approximately $1,313,853.58. The disclosure for this sale can be found here. In the last 90 days, insiders sold 25,429 shares of company stock valued at $3,686,927. 7.40% of the stock is owned by company insiders.

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Stock Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related stocks with our FREE daily email newsletter.